Company intelligence / Profile preview

SafeBVM

Boston, Massachusetts, United Statessafebvm.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

SafeBVM’s flagship product, Sotair, is an FDA 510(k)-cleared manual ventilation safety device that limits peak inspiratory flow to reduce risks of overventilation and associated complications. Clinical studies show significant improvements in peak pressures and tidal volumes during manual ventilation with the device. The company also offers SotairIQ, a training system providing real-time feedback on key ventilation parameters.

Therapeutic areas: PulmonologyCardiovascularNeurologyOther
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

National Institutes of Health/National Heart, Lung, and Blood Institute (funding/support)National Science Foundation (funding/support)Defense Health Agency/U.S. Air Force (funding/support)American Heart Association

Beyond the preview

Go deeper on SafeBVM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SafeBVM.

Explore the full profile